ALPS Awareness Lectures on Psychedelic Science
ALPS is the first Swiss non-profit foundation based in Geneva dedicated to sharing knowledge about the potential of psychedelic substances in psychiatry.
Our principles are those of critical rational thought, continuous learning and responsible autonomous decision-making.
Our motivation is intrinsic, stemming from a deep awareness that we can support efforts to provide access to the best possible therapeutic treatments for all those who need them.
We educate professionals and the public on evidence-based psychedelic research and therapy.
The biggest factor that makes us human is undeniably our sense of community and our continuous search for connection. Psychedelics have the potential not only to create connections in the brain, but also to connect humans to themselves, to each other and to the environment too.
What is it like to Trip? Notes from a phenomenological qualitative investigation | Jason K. Day
The Role of Subjective Experiences in Psychedelic-Assisted Psychotherapy | Nathan Strebel
Virtual Reality and Psychoplastogens: Toward pharmacologically altered VR Treatments | Hector Taylor
ALPS Conference 2025 Trailer
Psychedelics in Palliative Care: A Panel Discussion - ALPS Conference 2024
Psychedelics' Ability to modulate Social Behavior, Anxiety & Addiction by Dr. De Gregorio - Conf' 24
Psychedelic-Assisted Therapy in Practice - The Swiss Landscape by Dr. Aicher - ALPS Conference 2024
Ayahuasca Therapy for the Prevention of Prolonged Grief Disorder by Dr. Gonzalez - Conference '24
Working as a Couple in Psychedelic Therapy by Dr. Röskamp & Dr. Gasser - ALPS Conference 2024
Connectedness & Psychedelic Integration by Dr. Rosalind Watts - ALPS Conference 2024
Panel Discussion on Mystical Experiences induces by Psychedelic Substances - ALPS Conference 2024
Guidelines to address key issues in Psychedelic Science by Dr. Michiel Van Elk - ALPS Conference2024
Microphenomenology of 5-MeO-DMT by Dr. Anya Ermakova - ALPS Conference 2024
A Vegetal Turn for Psychedelic Plants and Fungi by Dr. Laura Pustarfi - ALPS Conference 2024
Psychedelics in Psychiatry by Dr. David Erritzoe - ALPS Conference 2024
ALPS Conference 2024 - Opening speech with a surprise guest
The Voices of ALPS - What is Morten looking forward to the most at ALPS 2024?
The Voices of ALPS - Meet Abigail our Research Project Coordinator
The Voices of ALPS - Philipp on why is ALPS so focused on Science?
Preventive and Behavioral Psychedelics: New Areas in Science ? by Pedro Teixeira at ALPS 2023
Understanding negative effects from psychedelics by Abigail Calder at ALPS 2023
Beyond Symptom Reduction - Observations from MDMA Research by Michael Mithoefer at ALPS 2023
Clinical settings unsuited for experiences of connectedness? by Christine Hauskeller at ALPS 2023
Exposure therapy under psilocybin for general anxiety disorder by Gabriel Thorens at ALPS 2023
Evaluating Psilocybin Effects on Multiple Entropy Metrics by Drummond McCulloch at ALPS 2023
Exploring Psychedelic Substances, Phase II and Clinical Studies by Yasmin Schmid at ALPS 2023